Free Trial

Precision BioSciences (DTIL) SEC Filings & 10K Form

Precision BioSciences logo
$5.91 +0.02 (+0.34%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$5.94 +0.02 (+0.42%)
As of 02/21/2025 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Precision BioSciences SEC Filings

DateFilerForm TypeView
02/14/2025
10:59 AM
Aquilo Capital Management, LLC (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:35 AM
JANUS HENDERSON GROUP PLC (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:01 AM
Lynx1 Capital Management LP (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G
01/29/2025
6:30 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
2:10 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
8:00 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:00 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:00 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:00 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
2:13 PM
Precision BioSciences (Subject)
SMITH J. JEFFERSON (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:14 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:19 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:05 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:00 AM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
6:00 AM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
6:00 AM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
5:10 AM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G/A
11/14/2024
10:00 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G
11/05/2024
6:14 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:14 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:14 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
2:49 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
2:51 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
6:15 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
6:15 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
7:45 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
7:03 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
6:30 AM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:30 AM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:30 AM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:30 AM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
6:30 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:30 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2024
7:00 AM
Precision BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/11/2024
4:12 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:13 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:13 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
2:12 PM
Precision BioSciences (Subject)
SMITH J. JEFFERSON (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

06/10/2024
2:15 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:36 PM
Precision BioSciences (Issuer)
Wadsworth Samuel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:36 PM
Pire Shari Lisa (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Frankel Stanley (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:37 PM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
6:15 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:15 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
7:25 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:25 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:26 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:26 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:19 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:26 PM
Precision BioSciences (Issuer)
Wadsworth Samuel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:26 PM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:26 PM
Pire Shari Lisa (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:25 PM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:25 PM
Frankel Stanley (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:25 PM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:29 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:30 PM
List Alan (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:32 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:33 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:34 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:20 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
2:43 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
2:46 PM
Precision BioSciences (Subject)
SMITH J. JEFFERSON (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
2:49 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
5:34 PM
List Alan (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
2:54 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2024
3:32 PM
Precision BioSciences (Filer)
Form DEF 14A
04/25/2024
3:34 PM
Precision BioSciences (Filer)
Form DEFA14A
04/25/2024
3:35 PM
Precision BioSciences (Filer)
Form ARS
04/22/2024
8:12 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
8:12 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
8:12 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
8:12 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:47 PM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
6:15 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
6:15 AM
Precision BioSciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
4:28 PM
Aquilo Capital Management, LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G
03/11/2024
10:21 AM
JANUS HENDERSON GROUP PLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G
03/01/2024
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
5:00 AM
Precision BioSciences (Subject)
Form FWP
02/29/2024
4:19 PM
Precision BioSciences (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DTIL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners